HuagongsheHuagongshe Chemistry Print Report · For research reference only
Morpholine → HCID 71252746, compound
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | Morpholine | HCID 8083 | — |
| Reactant | HCID 71252189 | HCID 71252189 | — |
| Product | HCID 71252746 | HCID 71252746 | — |
Reaction Steps
Using N,N-di-tert-butyloxycarbonyl-5-(1,1-dioxo-1λ6-isothiazolidin-2-yl)-2-[4-(5-ethyl-3-methylpyridin-2-yl)piperazine-1-carbonyl]benzamide (249 mg) described in Example 785 and morpholine (39 μL) and by the reaction and treatment in the same manner as in Example 770, the title compound (58 mg) was obtained.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US08816079B2 |
| Source dataset | uspto-grants-2014_08 |
| ORD ID | ord-bfcc1df3494b4cb6af1844c08b6421f6 |
| Source note | uspto-grants-2014_08 |